Bioprocess Digital Twins: Enabling Data-Driven Biomanufacturing

Oliver Hughes^*

Dept. of Systems Biotechnology, Cambridge North Univ., UK

*Corresponding Author:

Oliver Hughes
Dept. of Systems Biotechnology, Cambridge North Univ., UK
E-mail: o.hughes@cnu.ac.uk

Received: 01-May-2025, Manuscript No. fmpb-26-184959; Editor assigned: 03- May -2025, PreQC No. fmpb-26- 184959 (PQ); Reviewed: 17- May -2025, QC No. fmpb-26-184959; Revised: 22- May -2025, Manuscript No. fmpb-26-184959 (R); Published: 31- May -2025, DOI: 10.37532/2048- 9145.2025.13(3).257-258

Introduction

Bioprocess digital twins are virtual representations of physical biomanufacturing processes that integrate real-time data, mechanistic models, and advanced analytics to simulate and predict process behavior. By mirroring the performance of an actual bioprocess, digital twins provide enhanced process understanding, support decision-making, and enable proactive control strategies. As biomanufacturing becomes increasingly complex and data-rich, digital twins are emerging as a key technology for improving efficiency, consistency, and product quality across the process lifecycle [1,2].

Discussion

A bioprocess digital twin combines multiple modeling approaches, including first-principles models, statistical models, and machine learning algorithms. These models are continuously updated using data from sensors, process analytical technologies (PAT), and manufacturing execution systems. This integration allows the digital twin to reflect current process conditions and predict future outcomes under different operating scenarios.

Digital twins are applied across both upstream and downstream bioprocessing. In upstream operations, they can predict cell growth, metabolite profiles, and product formation, enabling optimization of feeding strategies and environmental conditions. In downstream processing, digital twins support chromatography optimization, filtration performance prediction, and capacity planning. By simulating process changes before implementation, manufacturers can reduce experimental costs and minimize production risks [3,4].

One of the key benefits of bioprocess digital twins is their ability to support real-time monitoring and control. When coupled with advanced control systems, digital twins enable predictive and prescriptive actions, such as adjusting process parameters to prevent deviations or maintain optimal performance. They also play a valuable role in technology transfer and scale-up by enabling virtual testing of process conditions at different scales.

Despite their potential, implementing bioprocess digital twins presents challenges. Developing accurate and reliable models requires high-quality data and deep process knowledge. Integration with existing digital infrastructure and ensuring data security are additional concerns. Regulatory acceptance also requires transparency, validation, and clear documentation of model performance and lifecycle management [5].

Conclusion

Bioprocess digital twins represent a powerful tool for advancing data-driven biomanufacturing. By providing real-time insight, predictive capability, and virtual experimentation, they enhance process understanding, control, and efficiency. While technical and regulatory challenges remain, ongoing advancements in modeling, analytics, and digital infrastructure are accelerating adoption. As biomanufacturing continues to evolve toward smart and connected systems, bioprocess digital twins are expected to become an essential component of next-generation manufacturing strategies.

References

1. Aslam J, Khan S, Siddiqui Z, Fatima Z, Maqsood, et al. (2010) Catharanthus roseus (L.) G. Don. An Important Drug: It’s Applications and Production. Pharm Glob (Ijcp) 4:1-16.

   Indexed at, Google Scholar, Crossref

2. Alba Bhutkar MA, Bhise SB (2011) Comparative Studies on Antioxidant Properties of Catharanthus Rosea and Catharanthus. International Journal of Pharmaceutical Techniques 3: 1551-1556.

   Indexed at, Google Scholar, Crossref

3. Nammi S, Boini M, Lodagala S, Behara (2003) The Juice Of Fresh Leaves Of Catharanthus roseus Linn Reduces Blood Glucose In Normal And Alloxan Diabetic Rabbits. BMC Complementary Medicine and Therapies 3:4.

   Indexed at, Google Scholar, Crossref

4. LCHHAAPM, Tiong SH (2013) Antidiabetic and Antioxidant Properties of Alkaloids from Catharanthus roseus. Molecules 18: 9770-9784.

   Indexed at, Google Scholar, Crossref

5. Ghosh S, Suryawanshi S (2001) Effect Of Vinca rosea Extracts In Treatment Of Alloxan Diabetes In Male Albino Rats. Indian J Exp Biol 39:748-759.

   Indexed at, Google Scholar